0001140361-16-060265.txt : 20160405 0001140361-16-060265.hdr.sgml : 20160405 20160405163926 ACCESSION NUMBER: 0001140361-16-060265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160401 FILED AS OF DATE: 20160405 DATE AS OF CHANGE: 20160405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEVRO CORP CENTRAL INDEX KEY: 0001444380 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 562568057 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-251-0005 MAIL ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elghandour Rami CENTRAL INDEX KEY: 0001613689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36715 FILM NUMBER: 161555014 MAIL ADDRESS: STREET 1: 15 BARCELONA CIR CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 doc1.xml FORM 4 X0306 4 2016-04-01 0 0001444380 NEVRO CORP NVRO 0001613689 Elghandour Rami C/O NEVRO CORP. 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 0 1 0 0 President Common Stock 2016-04-01 4 M 0 7000 3.60 A 71180 D Common Stock 2016-04-01 4 S 0 4500 60.8282 D 66680 D Common Stock 2016-04-01 4 S 0 2500 61.2831 D 64180 D Stock Option (right to buy) 3.60 2016-04-01 4 M 0 7000 0.00 D 2022-12-17 Common Stock 7000 123390 D Includes 63,695 RSUs. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $60.05 to $61.04, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $61.08 to $61.73, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option, representing the right to purchase 137,875 shares of the issuer's common stock, vests and becomes exercisable in respect to 25% of the original number of shares subject to the option on the first anniversary measured from November 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest and become exercisable in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares underlying to the option will be fully vested and exercisable on November 1, 2016, subject to the Reporting Person's continued service to the issuer. /s/ Andrew Galligan, as Attorney-in-Fact for Rami Elghandour 2016-04-05